Sparsomycin [sparsomycin]
topical
Persistent link
https://www.medvik.cz/link/D013033
Definition
An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems.
- Annotation
- an antineoplastic antibiotic
- DUI
- D013033 MeSH Browser
- CUI
- M0020197
- CAS
- 2-Propenamide, N-(1-(hydroxymethyl)-2-(((methylthio)methyl)sulfinyl)ethyl)-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-, (R-(R*,S*-(E)))-
- Previous indexing
- Antibiotics (1974); Antibiotics, Antineoplastic (1974); Ribonucleosides (1974)
- History note
- 91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90
- Public note
- 91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records